World’s first personalized CRISPR therapy given to baby with genetic disease
Posted:
A baby boy with a devastating genetic disease is thriving after becoming the first known person to receive a bespoke, CRISPR therapy-for-one, designed to correct his specific disease-causing mutation.
Little KJ Muldoon, now nearly ten months old, is doing well after receiving three doses of a gene-editing treatment
GIANT Health is delighted to welcome the NHS Innovation Accelerator (NIA) as a valued partner for GIANT Health 2026, where they will bring together a dedicated NIA Pavilion showcasing a selection of pioneering innovations helping to transform health and care…
GIANT Health Event 2026 is pleased to welcome MediWales as a media partner, strengthening connections between the global health technology community and Wales’ thriving life science ecosystem.
MediWales is the independent, not-for-profit life science network for Wales, bringing together organisations…
Attendees
Sponsors and Exhibitors
Contact us